DE69723984D1 - Inhibitoren der produktion von s-cd23 und der secretion von tnf - Google Patents

Inhibitoren der produktion von s-cd23 und der secretion von tnf

Info

Publication number
DE69723984D1
DE69723984D1 DE69723984T DE69723984T DE69723984D1 DE 69723984 D1 DE69723984 D1 DE 69723984D1 DE 69723984 T DE69723984 T DE 69723984T DE 69723984 T DE69723984 T DE 69723984T DE 69723984 D1 DE69723984 D1 DE 69723984D1
Authority
DE
Germany
Prior art keywords
tnf
secretion
inhibitors
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69723984T
Other languages
English (en)
Other versions
DE69723984T2 (de
Inventor
Stuart Bailey
Richard Buckle
Andrew Faller
Glynn Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of DE69723984D1 publication Critical patent/DE69723984D1/de
Application granted granted Critical
Publication of DE69723984T2 publication Critical patent/DE69723984T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69723984T 1996-05-10 1997-05-06 Inhibitoren der produktion von s-cd23 und der secretion von tnf Expired - Fee Related DE69723984T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9609794 1996-05-10
GBGB9609794.4A GB9609794D0 (en) 1996-05-10 1996-05-10 Novel compounds
PCT/EP1997/002433 WO1997043249A1 (en) 1996-05-10 1997-05-06 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF

Publications (2)

Publication Number Publication Date
DE69723984D1 true DE69723984D1 (de) 2003-09-11
DE69723984T2 DE69723984T2 (de) 2004-06-09

Family

ID=10793494

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69723984T Expired - Fee Related DE69723984T2 (de) 1996-05-10 1997-05-06 Inhibitoren der produktion von s-cd23 und der secretion von tnf

Country Status (21)

Country Link
US (1) US6235753B1 (de)
EP (1) EP0918747B1 (de)
JP (1) JP2000510473A (de)
KR (1) KR20000010892A (de)
AR (1) AR007060A1 (de)
AT (1) ATE246673T1 (de)
AU (1) AU2897397A (de)
BR (1) BR9709450A (de)
CA (1) CA2253590A1 (de)
CO (1) CO4990945A1 (de)
CZ (1) CZ363198A3 (de)
DE (1) DE69723984T2 (de)
ES (1) ES2205218T3 (de)
GB (1) GB9609794D0 (de)
IL (1) IL126860A0 (de)
NO (1) NO985214L (de)
NZ (1) NZ332628A (de)
PL (1) PL329855A1 (de)
TR (1) TR199802271T2 (de)
WO (1) WO1997043249A1 (de)
ZA (1) ZA973964B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082200A1 (en) * 1994-07-13 2002-06-27 Smithkline Beecham P.1.C. Use of inhibitors of human S-CD23
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
AUPO721997A0 (en) * 1997-06-06 1997-07-03 Queensland Institute Of Medical Research, The Anticancer compounds
EP1030851B1 (de) * 1997-11-12 2005-01-12 Darwin Discovery Limited Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität
GB9813451D0 (en) * 1998-06-22 1998-08-19 Smithkline Beecham Plc Novel compounds
GB9922825D0 (en) * 1999-09-25 1999-11-24 Smithkline Beecham Biolog Medical use
US6541661B1 (en) 1999-11-23 2003-04-01 Methylgene, Inc. Inhibitors of histone deacetylase
GB9930754D0 (en) * 1999-12-29 2000-02-16 Smithkline Beecham Plc Novel compounds
US7652036B2 (en) 2003-02-25 2010-01-26 Topotarget Uk Limited Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors
GB0818907D0 (en) * 2008-10-15 2008-11-19 Isis Innovation Histone lysine demethylase inhibitors
SG176010A1 (en) 2009-05-28 2011-12-29 Novartis Ag Substituted aminobutyric derivatives as neprilysin inhibitors
AU2010251967B9 (en) * 2009-05-28 2014-04-03 Novartis Ag Substituted aminopropionic derivatives as neprilysin inhibitors
US8945575B2 (en) 2009-12-01 2015-02-03 Trustees Of Boston University Treatment of IgE-mediated disease
JP6295277B2 (ja) 2013-02-14 2018-03-14 ノバルティス アーゲー Ｎｅｐ（中性エンドペプチダーゼ）阻害剤としての置換ビスフェニルブタン酸ホスホン酸誘導体
CA2900226A1 (en) 2013-02-14 2014-08-21 Novartis Ag Substituted bisphenyl butanoic acid derivatives as nep inhibitors with improved in vivo efficacy
CA2963875A1 (en) * 2014-11-19 2016-05-26 Actelion Pharmaceuticals Ltd Antibacterial benzothiazole derivatives
CN113194954A (zh) 2018-10-04 2021-07-30 国家医疗保健研究所 用于治疗角皮病的egfr抑制剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9215665D0 (en) * 1992-07-23 1992-09-09 British Bio Technology Compounds
ES2144819T3 (es) * 1994-01-20 2000-06-16 British Biotech Pharm L-terc-leucina-2-piridilamida.
GB9414157D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Medical use
US5562917A (en) 1994-12-23 1996-10-08 Pentech Pharmaceuticals, Inc. Transdermal administration of apomorphine
DE19506492C2 (de) 1995-02-24 2003-05-08 Focke & Co Einrichtung zum Speichern von Zigaretten oder dergleichen
US5570079A (en) 1995-04-24 1996-10-29 Dockery; Devan Home security system for detecting an intrusion into a monitored area by an infrared detector

Also Published As

Publication number Publication date
EP0918747A1 (de) 1999-06-02
PL329855A1 (en) 1999-04-12
JP2000510473A (ja) 2000-08-15
NO985214D0 (no) 1998-11-09
CZ363198A3 (cs) 1999-06-16
WO1997043249A1 (en) 1997-11-20
NO985214L (no) 1998-12-01
CO4990945A1 (es) 2000-12-26
BR9709450A (pt) 1999-08-10
US6235753B1 (en) 2001-05-22
TR199802271T2 (xx) 2000-08-21
KR20000010892A (ko) 2000-02-25
AR007060A1 (es) 1999-10-13
AU2897397A (en) 1997-12-05
ES2205218T3 (es) 2004-05-01
ZA973964B (en) 1998-11-09
IL126860A0 (en) 1999-09-22
CA2253590A1 (en) 1997-11-20
DE69723984T2 (de) 2004-06-09
GB9609794D0 (en) 1996-07-17
EP0918747B1 (de) 2003-08-06
ATE246673T1 (de) 2003-08-15
NZ332628A (en) 2000-06-23

Similar Documents

Publication Publication Date Title
DE69723984D1 (de) Inhibitoren der produktion von s-cd23 und der secretion von tnf
NO960552D0 (no) Elektrode og fremstilling av elektroden
DE69820397D1 (de) Ätzmittel und ihre Verwendung
NO991433D0 (no) Heterosykliske estere og amider
NO180145C (no) Tannbörste og tildannelse av samme
DE69821072D1 (de) Echtzeit bildgesteuerte Positionierung von Verankerungseinheiten
DK0791190T3 (da) Signaleringsgenstande og fremgangsmåde til fremstilling af samme
DE69738197D1 (de) Azolotriazine und pyrimidine
NO975245L (no) Heterocykluser som inhibitorer av leukosyttadhesjon og VLA-4-antagonister
DE69703584D1 (de) Kaskadierter anschluss von kommunizierenden geräte
FI960803A0 (fi) TNF-alfa-sekreetion inhibiittoreita
PL333505A1 (en) Benzamido-aldehydes and their application as inhibitors of cysteinic proteases
DE69411692T2 (de) Mittel zur Förderung der Proliferationen von Bifidobacterium
FI963655A0 (fi) Polypeptidien parannettu eritys
NO984094D0 (no) Utladningsreaktor og anvendelse av samme
DE69501493T2 (de) Entfernung von Feuchtigkeit und Passivierung von Oberflächen
FI980246A0 (fi) Menetelmä keittimen käyttämiseksi ja keitin
DE69716556D1 (de) Längsgestreckter Vliesstoff und dessen Herstellungsverfahren
DE69737335D1 (de) Festelektrolytkondensator und dessen Herstellungsverfahren
DE69717677T2 (de) Koproduktion von perfluormethylperfluorvinylether und perfluorethylperfluorvinylether
DE69524590T2 (de) Zusammensetzung von 5htida und 5htid antagonisten
DE69731897D1 (de) Decken-einbau von beleuchtungs- oder anderen geräten
IS5356A (is) Viss bensóþíasíndíoxíð-mótlyf gegn endóþelíni og ferli til að smíða þau
DE59700145D1 (de) Trainingsstation und Verwendung der Trainingsstation
DE69732095D1 (de) Ionomerzusammensetzung und ihre verwendung

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee